This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Asia: Oligonucleotide & Peptide Therapeutics
24-26 Feb, 2026
Grand Nikko Tokyo DaibaTokyo

Dr. Stefano Zanotti, PhD
Senior Vice President at Dyne Therapeutics
Speaker

Profile

Stefano Zanotti, Ph.D. serves as Senior Vice President of Neuromuscular Research at Dyne Therapeutics, where he oversees a multidisciplinary research team dedicated to discovering and developing treatments for rare neuromuscular diseases. Stefano committed his career to genetic disorders; before Dyne, he was Director of Rare Renal and Musculoskeletal Diseases at Sanofi where he led multiple research programs in rare disease indications. Stefano started his post-doctoral career as an Assistant Professor at the University of Connecticut, where he conducted NIH-funded research focused on genetic disorders of the skeleton. Stefano has published numerous reviews, book chapters, and more than 50 research articles in major scientific journals, and he’s a regular presenter at international scientific congresses.

Agenda Sessions

  • FORCE Platform Enables TfR1-mediated Delivery of Therapeutics for Rare Neuromuscular Diseases

    8:45am